Related Experiment Video

Updated: Jul 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation

Hongying Hao1, Yanbin Dong, Maria T Bowling

  • 1Department of Surgery, University of Louisville, Louisville, KY 40292, USA. h0hao001@louisville.edu <h0hao001@louisville.edu>

BMC Cancer
|February 1, 2007
PubMed
Abstract

Insights

This study shows that E2F-1 induces melanoma cell death by increasing PUMA protein levels and promoting Bax translocation. These findings clarify the molecular mechanisms of E2F-1-driven apoptosis for potential cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • PUMA (Pro-apoptotic Ubiquitin Modifying Activating enzyme) is a key regulator of apoptosis within the Bcl-2 family.
  • Its role in E2F-1-induced apoptosis in melanoma cells requires further elucidation.

Purpose of the Study:

  • To investigate the role of PUMA induction in E2F-1-mediated apoptosis in melanoma cells.
  • To elucidate the signaling pathways involved in E2F-1-induced apoptosis.

Main Methods:

  • Real-time PCR and Western blot to assess PUMA gene and protein expression.
  • Dual luciferase reporter assay to evaluate PUMA promoter activity.
  • Immunocytochemistry and caspase-9 assay to analyze apoptosis markers.

Main Results:

  • E2F-1 overexpression up-regulated PUMA gene and protein in melanoma cells.
  • E2F-1 directly activated the PUMA promoter, indicating PUMA is a transcriptional target.
  • PUMA deficiency rendered cells more resistant to E2F-1-induced apoptosis.
  • E2F-1-induced apoptosis involved Bax translocation and caspase-9 activation.

Conclusions:

  • E2F-1 induces melanoma apoptosis through PUMA up-regulation and Bax translocation.
  • The findings provide mechanistic insights into E2F-1-induced apoptosis, relevant for cancer therapy development.

More Related Videos

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.